4/A

FORM 4/A SUBMISSION

Company: PLUS THERAPEUTICS, INC.
Filed: March 28, 2022
Period of Report: November 11, 2021
Accession Number: 0000899243-22-012518

View Document ↗ View on SEC.gov ↗